- Home
- BMRN vs ELS Comparison
BMRN vs ELS Comparison
Compare BMRN & ELS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMRN
- ELS
- Stock Information
- Founded
- BMRN 1996
- ELS 1992
- Country
- BMRN United States
- ELS United States
- Employees
- BMRN N/A
- ELS N/A
- Industry
- BMRN Biotechnology: Pharmaceutical Preparations
- ELS Real Estate Investment Trusts
- Sector
- BMRN Health Care
- ELS Real Estate
- Exchange
- BMRN Nasdaq
- ELS Nasdaq
- Market Cap
- BMRN 10.5B
- ELS 12.0B
- IPO Year
- BMRN 1999
- ELS 1993
- Fundamental
- Price
- BMRN $54.29
- ELS $61.93
- Analyst Decision
- BMRN Buy
- ELS Buy
- Analyst Count
- BMRN 19
- ELS 11
- Target Price
- BMRN $90.26
- ELS $70.86
- AVG Volume (30 Days)
- BMRN 2.8M
- ELS 2.1M
- Earning Date
- BMRN 10-27-2025
- ELS 10-22-2025
- Dividend Yield
- BMRN N/A
- ELS 3.34%
- EPS Growth
- BMRN 59.53
- ELS 2.36
- EPS
- BMRN 2.68
- ELS 1.99
- Revenue
- BMRN $3,094,001,000.00
- ELS $1,535,911,000.00
- Revenue This Year
- BMRN $13.32
- ELS $1.15
- Revenue Next Year
- BMRN $7.51
- ELS $4.52
- P/E Ratio
- BMRN $20.20
- ELS $30.95
- Revenue Growth
- BMRN 12.39
- ELS 0.93
- 52 Week Low
- BMRN $50.76
- ELS $58.15
- 52 Week High
- BMRN $73.51
- ELS $72.81
- Technical
- Relative Strength Index (RSI)
- BMRN 53.35
- ELS 52.40
- Support Level
- BMRN $53.67
- ELS $61.54
- Resistance Level
- BMRN $55.34
- ELS $62.47
- Average True Range (ATR)
- BMRN 1.49
- ELS 1.02
- MACD
- BMRN 0.28
- ELS 0.06
- Stochastic Oscillator
- BMRN 78.60
- ELS 68.03
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.
About ELS Equity Lifestyle Properties Inc.
Equity Lifestyle Properties is a residential REIT that focuses on owning manufactured housing, residential vehicle communities, and marinas. The company currently has a portfolio of 455 properties across the U.S. with a higher concentration in the Sunbelt region with 38% of the company's properties located in Florida, 12% in Arizona, and 8% in California. Equity Lifestyle targets owning properties in attractive retirement destinations with over 70% of the company's properties either being age-restricted or having an average resident age over 55.